BerGenBio
Clinical-stage biopharma that developed selective AXL kinase inhibitors for cancer.
BGBIO | OL
Overview
Corporate Details
- ISIN(s):
- NO0012921180 (+2 more)
- LEI:
- 213800TYYFXKYF3V2A23
- Country:
- Norway
- Address:
- MØLLENDALSBAKKEN 9, 5009 BERGEN
- Website:
- https://www.bergenbio.com/
- Sector:
- Manufacturing
Description
BerGenBio was a clinical-stage biopharmaceutical company focused on developing first-in-class selective AXL kinase inhibitors. The company's therapeutic candidates targeted AXL as a potential cornerstone of therapy for aggressive, advanced, and treatment-resistant cancers. In October 2025, BerGenBio completed a merger with Oncoinvent ASA, and the combined entity was renamed Oncoinvent.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-01-06 09:30 |
BERGENBIO APPOINTS ANDERS TULLGREN AS CHAIRMAN OF BOARD
|
English | 4.8 KB | ||
| 2022-01-06 09:27 |
BerGenBio ASA: Extraordinary General Meeting held
|
Norwegian | 1.3 MB | ||
| 2022-01-06 09:27 |
BerGenBio ASA: Extraordinary General Meeting held
|
English | 159.0 KB | ||
| 2022-01-06 09:27 |
BerGenBio ASA: Extraordinary General Meeting held
|
English | 1.7 KB | ||
| 2022-01-06 07:58 |
BerGenBio - Mandatory notification of trade by Primary Insiders
|
English | 126.2 KB | ||
| 2022-01-06 07:58 |
BerGenBio - Mandatory notification of trade by Primary Insiders
|
English | 126.1 KB | ||
| 2022-01-06 07:58 |
BerGenBio - Mandatory notification of trade by Primary Insiders
|
English | 967 bytes | ||
| 2021-12-17 12:43 |
Financial calendar
|
English | 899 bytes | ||
| 2021-12-16 14:00 |
BerGenBio ASA: Notice of Extraordinary General Meeting
|
Norwegian | 273.0 KB | ||
| 2021-12-16 14:00 |
BerGenBio ASA: Notice of Extraordinary General Meeting
|
Norwegian | 172.5 KB | ||
| 2021-12-16 14:00 |
BerGenBio ASA: Notice of Extraordinary General Meeting
|
Norwegian | 105.4 KB | ||
| 2021-12-16 14:00 |
BerGenBio ASA: Notice of Extraordinary General Meeting
|
English | 3.4 KB | ||
| 2021-12-16 06:30 |
BerGenBio announces exclusive in-license of key intellectual property rights fr…
|
English | 141.7 KB | ||
| 2021-12-16 06:30 |
BerGenBio announces exclusive in-license of key intellectual property rights fr…
|
English | 4.5 KB | ||
| 2021-12-14 06:43 |
BerGenBio to present at DNB Nordic Healthcare Conference 2021
|
English | 129.9 KB |
Automate Your Workflow. Get a real-time feed of all BerGenBio filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BerGenBio
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BerGenBio via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
